Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP‐sensitive potassium channels.

1. Nitric oxide (NO) relaxes vascular smooth muscle (VSM) by mechanisms which are not fully understood. One possibility is that NO hyperpolarizes membranes, thereby diminishing Ca2+ entry through voltage‐dependent Ca2+ channels. In the current study, the effects of NO on membrane potential of rabbit mesenteric arteries were recorded using intracellular microelectrodes. 2. NO, released by 3‐morpholinosydnonimine (SIN‐1, 3 microM), reversibly hyperpolarized arteries by ‐9.5 +/‐ 4.0 mV (means +/‐ S.D., n = 97) from a resting membrane potential of ‐53.1 +/‐ 5.7 mV. The hyperpolarization was blocked by oxyhaemoglobin (20 microM), and only occurred in arteries pre‐treated with N omega‐nitro‐L‐arginine (100 microM) or denuded of endothelium. 3. The effect of SIN‐1 was concentration dependent (EC50 approximately 0.4 microM) and its dose response was shifted to the left by zaprinast (100 microM), an inhibitor of cGMP‐specific phosphodiesterases. 4. The hyperpolarization due to SIN‐1 was modified by changes in extracellular K+ concentration, but not by changes in Ca2+, Na+ or Cl‐. The hyperpolarization was blocked by glibenclamide (IC50 approximately 0.15 microM), but not by apamin (3‐300 nM), barium (5‐150 microM), tetraethylammonium (0.1‐10 mM), or 4‐aminopyridine (5‐500 microM). The hyperpolarization due to lemakalim (0.03‐3 microM), an activator of ATP‐sensitive potassium channels (KATP), displayed the same sensitivities to these K+ channel blocking agents, whereas the endothelium‐derived hyperpolarizing factor, triggered by the addition of acetylcholine (3 microM), caused a hyperpolarization (‐15.3 +/‐ 6.2 mV) that was blocked by apamin, but not by any other agent. 5. These results suggest that NO hyperpolarizes VSM in rabbit mesenteric arteries by activating KATP channels, with the accumulation of cGMP as an intermediate step.

[1]  Y. Nakaya,et al.  Atrial natriuretic factor and isosorbide dinitrate modulate the gating of ATP-sensitive K+ channels in cultured vascular smooth muscle cells. , 1994, Circulation research.

[2]  A. Bonev,et al.  Calcitonin gene‐related peptide activated ATP‐sensitive K+ currents in rabbit arterial smooth muscle via protein kinase A. , 1994, The Journal of physiology.

[3]  M. Nelson,et al.  Inward rectifier K+ currents in smooth muscle cells from rat resistance-sized cerebral arteries. , 1993, The American journal of physiology.

[4]  C. Garland,et al.  Differential effects of acetylcholine, nitric oxide and levcromakalim on smooth muscle membrane potential and tone in the rabbit basilar artery , 1993, British journal of pharmacology.

[5]  B. E. Robertson,et al.  cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. , 1993, The American journal of physiology.

[6]  H. Coleman,et al.  Stretch revealed three components in the hyperpolarization of guinea‐pig coronary artery in response to acetylcholine. , 1993, The Journal of physiology.

[7]  C. Triggle,et al.  Varying Extracellular [K+]: A Functional Approach to Separating EDHF‐ and EDNO‐Related Mechanisms in Perfused Rat Mesenteric Arterial Bed , 1993, Journal of cardiovascular pharmacology.

[8]  J. Corbin,et al.  Cross-activation: overriding cAMP/cGMP selectivities of protein kinases in tissues. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[9]  D. Landry,et al.  The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog. , 1992, The Journal of clinical investigation.

[10]  C. Garland,et al.  Endothelium‐dependent relaxation to acetylcholine in the rabbit basilar artery: importance of membrane hyperpolarization , 1992, British journal of pharmacology.

[11]  D. Eckman,et al.  Comparison of the actions of acetylcholine and BRL 38227 in the guinea‐pig coronary artery , 1992, British journal of pharmacology.

[12]  P. Krippeit-Drews,et al.  Effect of Nitric Oxide on Membrane Potential and Contraction of Rat Aorta , 1992, Journal of cardiovascular pharmacology.

[13]  M. Fujishima,et al.  Decreased endothelium-dependent hyperpolarization to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. , 1992, Circulation research.

[14]  C. Garland,et al.  Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery , 1992, British journal of pharmacology.

[15]  P. Vallance,et al.  Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock , 1991, The Lancet.

[16]  R. Kovacs,et al.  ATP-sensitive K+ channels from aortic smooth muscle incorporated into planar lipid bilayers. , 1991, The American journal of physiology.

[17]  M. Garcia-Calvo,et al.  Use of toxins to study potassium channels , 1991, Journal of bioenergetics and biomembranes.

[18]  Y. Yamamoto,et al.  Hyperpolarization of arterial smooth muscle induced by endothelial humoral substances. , 1991, The American journal of physiology.

[19]  J. Brayden Membrane hyperpolarization is a mechanism of endothelium-dependent cerebral vasodilation. , 1990, The American journal of physiology.

[20]  G. Dusting,et al.  Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium , 1990, Nature.

[21]  T. Bolton,et al.  Two components of potassium current activated by depolarization of single smooth muscle cells from the rabbit portal vein. , 1989, The Journal of physiology.

[22]  E. Sybertz,et al.  Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta. , 1989, Biochemical pharmacology.

[23]  N. Standen,et al.  Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. , 1989, Science.

[24]  D. Harder,et al.  Mechanism of Action of EDRF on Pressurized Arteries: Effect on K+ Conductance , 1989, Circulation research.

[25]  H. Suzuki,et al.  Some electrical properties of the endothelium‐dependent hyperpolarization recorded from rat arterial smooth muscle cells. , 1989, The Journal of physiology.

[26]  D. Williams,et al.  Guanosine 5'-monophosphate modulates gating of high-conductance Ca2+-activated K+ channels in vascular smooth muscle cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[27]  N. Standen,et al.  The voltage‐dependent block of ATP‐sensitive potassium channels of frog skeletal muscle by caesium and barium ions. , 1988, The Journal of physiology.

[28]  K. Komori,et al.  Nitric oxide, ACh, and electrical and mechanical properties of canine arterial smooth muscle. , 1988, The American journal of physiology.

[29]  A. Weston,et al.  Endothelium‐dependent effects of acetylcholine in rat aorta: a comparison with sodium nitroprusside and cromakalim , 1988, British journal of pharmacology.

[30]  D. W. Cheung,et al.  The effects of sodium nitroprusside and 8‐bromo‐cyclic GMP on electrical and mechanical activities of the rat tail artery , 1985, British journal of pharmacology.

[31]  A. Sjöqvist,et al.  The effect of apamin on non‐adrenergic, non‐cholinergic vasodilator mechanisms in the intestines of the cat. , 1983, The Journal of physiology.

[32]  H. Suzuki,et al.  Effects of sodium nitroprusside on smooth muscle cells of rabbit pulmonary artery and portal vein. , 1978, The Journal of pharmacology and experimental therapeutics.

[33]  H. Strauss,et al.  Intracellular calcium, currents, and stimulus-response coupling in endothelial cells. , 1993, Hypertension.

[34]  Shakil Ahmed Khan,et al.  Vascular pharmacology of ATP-sensitive K+ channels: interactions between glyburide and K+ channel openers. , 1993, Journal of vascular research.

[35]  R. Hetzer,et al.  Role of prostacyclin in normal and arteriosclerotic human coronary arteries during hypoxia. , 1992, Agents and actions. Supplements.

[36]  R Latorre,et al.  Varieties of calcium-activated potassium channels. , 1989, Annual review of physiology.

[37]  M. Feelisch,et al.  On the Mechanism of NO Release from Sydnonimines , 1989, Journal of cardiovascular pharmacology.